EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbial metabolic memory in inflammatory bowel disease: microbiota-derived metabolites, host–microbe reprogramming, and relapse susceptibility

Xiaozhen Cheng, Tao Zhang, Mengying Zhu, Zhengchao Pan, Meng Chen, Weilin Li, Ru Man, Xiangdong Zhao, Yongduo Yu

Frontiers in Microbiology · 29.07.2026 · 17

DOI: 10.3389/fmicb.2026.1893807 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.07.2026. Verfasst von Xiaozhen Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is increasingly recognized as a disorder of disrupted host–microbe metabolic communication rather than a consequence of microbial dysbiosis alone. Gut microbiota-derived metabolites, including short-chain fatty acids, tryptophan derivatives, bile acid metabolites, polyamines, lactate, succinate, and trimethylamine N-oxide, act as functional mediators linking microbial ecological changes to epithelial barrier integrity, mucosal immune activation, inflammatory amplification, and tissue repair. However, most existing discussions have focused on individual metabolites or isolated immune pathways, leaving the dynamic and disease-stage-specific nature of microbial metabolic remodeling insufficiently defined. In this review, we reframe IBD pathogenesis from the perspective of microbial metabolic memory, emphasizing how persistent alterations in microbial metabolic output may imprint epithelial and immune cell responses even after clinical remission. We summarize how protective metabolite depletion and proinflammatory metabolite accumulation contribute to immune tolerance breakdown, barrier dysfunction, inflammatory propagation, extraintestinal immune manifestations, and relapse susceptibility. We further discuss how mucosal inflammation reciprocally reshapes microbial niches, oxygen tension, nutrient availability, and metabolic pathway activity, thereby establishing self-reinforcing host–microbe feedback loops. Finally, we evaluate emerging therapeutic strategies, including metabolite supplementation, blockade of proinflammatory metabolic signaling, microbiota-based metabolic remodeling, engineered probiotics, and metabolomics-guided precision interventions. This metabolic-memory framework may provide a more integrated basis for understanding IBD recurrence and for developing microbiota-targeted strategies aimed at restoring durable intestinal homeostasis.

Schlagwörter

Stichwörter der Autor:innen

gut microbiotahost–microbe interactioninflammatory bowel diseasemetabolic memorymetabolomicsmicrobial metabolitesmucosal immunityrelapse

Autor:innen und Institutionen

  • Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
  • Liaoning University of Traditional Chinese Medicine, Shenyang, China.
  • Second Affiliated Hospital, Liaoning University of Traditional Chinese Medicine, Shenyang, China.

Zitieren

APA

Cheng, X., Zhang, T., Zhu, M., Pan, Z., Chen, M., Li, W., Man, R., Zhao, X., & Yu, Y. (2026). Microbial metabolic memory in inflammatory bowel disease: microbiota-derived metabolites, host–microbe reprogramming, and relapse susceptibility. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1893807

Vancouver

Cheng X, Zhang T, Zhu M, Pan Z, Chen M, Li W, et al. Microbial metabolic memory in inflammatory bowel disease: microbiota-derived metabolites, host–microbe reprogramming, and relapse susceptibility. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1893807

BibTeX
@article{Cheng2026,
  author = {Cheng, Xiaozhen and Zhang, Tao and Zhu, Mengying and Pan, Zhengchao and Chen, Meng and Li, Weilin and Man, Ru and Zhao, Xiangdong and Yu, Yongduo},
  title = {Microbial metabolic memory in inflammatory bowel disease: microbiota-derived metabolites, host–microbe reprogramming, and relapse susceptibility},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1893807}
}
Kostenlos starten →